while all of the drugs work on cgrp, they don�t all work the same way. three of them target the cgrp molecule itself. aimovig goes after cgrp's receptor in the brain....
.
david dodick, md, neurologist, mayo clinic; chairman, american migraine foundation..
"the drug must be administered at the right time point during development," he said..
despite neutral imaging results, adalimumab did improve other key markers of inflammation in the blood including glyca, crp, tnf, and il-6..